The lecture video:0
Abstract:27
1667
0
0
Date (UTC+8) | Time (UTC+8) | Local Time | Room | Session | Role | Talk Title |
---|---|---|---|---|---|---|
2022-09-16 | 08:30-10:00 | 2022-09-16,08:30-10:00 | Meeting Room 1 |
State-of-the-art Session 1 |
Guests | |
2022-09-16 | 11:45-13:15 | 2022-09-16,11:45-13:15 | Meeting Room 1 |
Oral Presentation 1 |
Guests | |
2022-09-16 | 13:15-13:30 | 2022-09-16,13:15-13:30 | Meeting Room 1 |
Satellite Symposium |
Speaker | Clinical value of highly sensitive detection in CHB LLV patients |
2022-09-16 | 13:15-15:15 | 2022-09-16,13:15-15:15 | Meeting Room 2 |
Young Investigator Froum 1 |
Discussant | |
2022-09-16 | 18:00-18:20 | 2022-09-16,18:00-18:20 | Meeting Room 1 |
Postgraduate Course 3 - Liver Failure |
Speaker | Management of end-stage liver disease complicated with infections |
2022-09-17 | 10:20-10:40 | 2022-09-17,10:20-10:40 | Meeting Room 3 |
Concurrent Session 3 - Hepatic Encephalopathy |
Speaker | A Quick and Early Diagnostic Model for Minimal Hepatic Encephalopathy in ESLD |
2022-09-17 | 11:45-13:15 | 2022-09-17,11:45-13:15 | Meeting Room 2 |
Oral Presentation 4 |
Moderator | |
2022-09-17 | 13:15-13:30 | 2022-09-17,13:15-13:30 | Meeting Room 1 |
Satellite Symposium |
Chair | |
2022-09-17 | 18:30-18:45 | 2022-09-17,18:30-18:45 | Meeting Room 1 |
Satellite Symposium |
Speaker | Advantages of DPMAS in the treatment of HBV-ACLF |
2022-09-18 | 10:40-11:00 | 2022-09-18,10:40-11:00 | Meeting Room 3 |
Concurrent Session 12 - Management of ACLF |
Speaker | Diagnosis and treatment of end-stage liver disease combined with severe infection |